Cellect Biotech/S (Apop) Lowered to "Hold" at Zacks Investment Research

Cellect Biotech/S (Apop) Lowered to "Hold" at Zacks Investment Research


According to Zacks, "Cellect Biotechnology Ltd. offers biomedical services. It provides stem cell transplantation, disease management, regenerative medicine, clinical research and other services.



from Biotech News